Mutual Fund Equity Report fund seekers should consider taking a look at Neuberger Berman Mid Cap Growth A (NMGAX). NMGAX bears a Zacks Mutual Fund Rank of 2 (Buy), which is based on nine forecasting factors like size, cost, and past performance.History of Fund/ManagerNeuberger is responsible for NMGAX, and the company is based out of New York, NY. Neuberger Berman Mid Cap Growth A debuted in May of 1998. Since then, NMGAX has accumulated assets of about $48.40 million, according to the most recently available information. A team of investment professionals is the fund's current manager.PerformanceInvestors naturally seek funds with strong performance. This fund in particular has delivered a 5-year annualized total return of 10.65%, and is in the middle third among its category peers. Investors who prefer analyzing shorter time frames should look at its 3-year annualized total return of 7.81%, which places it in the middle third during this time-frame.When looking at a fund's performance, it is also important to note the standard deviation of the returns. The lower the standard deviation, the less volatility the fund experiences. Over the past three years, NMGAX's standard deviation comes in at 23.51%, compared to the category average of 16.83%. The fund's standard deviation over the past 5 years is 21.24% compared to the category average of 14.95%. This makes the fund more volatile than its peers over the past half-decade.Risk FactorsWith a 5-year beta of 1.06, the fund is likely to be more volatile than the market average. Another factor to consider is alpha, as it reflects a portfolio's performance on a risk-adjusted basis relative to a benchmark-in this case, the S&P 500. With a negative alpha of -1.1, managers in this portfolio find it difficult to pick securities that generate better-than-benchmark returns.HoldingsInvestigating the equity holdings of a mutual fund is also a valuable exercise. This can show us how the manager is applying their stated methodology, as well as if there are any inherent biases in their approach. For this particular fund, the focus is primarily on equities that are traded in the United States.As of the last filing date, the mutual fund has 86.21% of its assets in stocks, with an average market capitalization of $22.13 billion. The fund has the heaviest exposure to the following market sectors: Technology Retail Trade Turnover is 46%, which means this fund makes fewer trades than comparable funds.ExpensesCosts are increasingly important for mutual fund investing, and particularly as competition heats up in this market. And all things being equal, a lower cost product will outperform its otherwise identical counterpart, so taking a closer look at these metrics is key for investors. In terms of fees, NMGAX is a load fund. It has an expense ratio of 1.03% compared to the category average of 1.14%. NMGAX is actually cheaper than its peers when you consider factors like cost.Investors need to be aware that with this product, the minimum initial investment is $1,000; each subsequent investment needs to be at least $100.Bottom LineOverall, Neuberger Berman Mid Cap Growth A ( NMGAX ) has a high Zacks Mutual Fund rank, and in conjunction with its comparatively similar performance, worse downside risk, and lower fees, Neuberger Berman Mid Cap Growth A ( NMGAX ) looks like a good potential choice for investors right now.Your research on the Mutual Fund Equity Report segment doesn't have to stop here. You can check out all the great mutual fund tools we have to offer by going to www.zacks.com/funds/mutual-funds to see the additional features we offer as well for additional information. Want to learn even more? We have a full suite of tools on stocks that you can use to find the best choices for your portfolio too, no matter what kind of investor you are. Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time. This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Get Your Free (NMGAX): Fund Analysis Report To read this article on Zacks.com click here. Zacks Investment Research